Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
kallikrein related peptidase 3 | 0.443 | 0.885 | 4.4E-06 |
|
disease | 0.200 | None | 0.957 | 1855 | 15 | 1991 | 2020 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.100 | None | 0.982 | 1850 | 14 | 1990 | 2020 | ||||||||
|
folate hydrolase 1 | 0.453 | 0.885 | 6.2E-09 |
|
disease | 0.100 | None | 0.982 | 653 | 4 | 1995 | 2020 | ||||||||
|
phosphoserine aminotransferase 1 | 0.478 | 0.846 | 1.1E-08 |
|
disease | 0.100 | None | 0.968 | 558 | 3 | 1994 | 2020 | ||||||||
|
PLAG1 zinc finger | 0.493 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0.968 | 558 | 2 | 1994 | 2020 | ||||||||
|
protein S | 0.467 | 0.846 | 4.7E-04 |
|
disease | 0.100 | None | 0.968 | 558 | 1 | 1994 | 2020 | ||||||||
|
aminopeptidase puromycin sensitive | 0.519 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0.968 | 558 | 1 | 1994 | 2020 | ||||||||
|
ETS transcription factor ERG | 0.453 | 0.808 | 0.96 |
|
disease | 0.100 | None | 0.967 | 394 | 3 | 2005 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.944 | 304 | 9 | 1991 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.100 | None | 0.969 | 292 | 1 | 1997 | 2020 | ||||||||
|
transmembrane serine protease 2 | 0.615 | 0.500 | 2.4E-10 |
|
disease | 0.100 | None | 0.971 | 240 | 1 | 2001 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.100 | None | 0.955 | 133 | 5 | 1997 | 2020 | ||||||||
|
glutathione S-transferase pi 1 | 0.383 | 0.923 | 1.4E-02 |
|
disease | 0.100 | None | 0.947 | 131 | 3 | 1994 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.984 | 125 | 0 | 2003 | 2020 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.200 | None | 0.960 | 123 | 6 | 1996 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.984 | 122 | 0 | 2003 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.983 | 121 | 1 | 2003 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.100 | None | 0.983 | 121 | 0 | 2003 | 2020 | ||||||||
|
prostate cancer associated 3 | 0.663 | 0.615 |
|
disease | 0.100 | None | 0.974 | 116 | 1 | 2000 | 2020 | |||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.100 | None | 0.930 | 100 | 6 | 1995 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.968 | 94 | 0 | 1998 | 2020 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.989 | 92 | 0 | 2002 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.977 | 86 | 1 | 1998 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.100 | None | 0.943 | 70 | 3 | 1992 | 2020 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.100 | None | 0.984 | 61 | 1 | 1998 | 2020 |